Who Paid My Doc Search
Menu
Organisation paid for research Program year 2022 Source: CMS Open Payments

Covigilant Rsrch LLC

Neither a doctor nor a teaching hospital

Research payments

$237,804

240 payments

Through program year 2022, Covigilant Rsrch LLC is reported as receiving $237,804 in research payments, across 240 payments.

By program year

4 rows
Year Kind Amount Payments
2022 Research $250 1
2021 Research $21,284 29
2020 Research $64,643 75
2019 Research $151,628 135

Breakdown

Who paid Research payments · program years 2019–2022
  1. Boehringer Ingelheim International GmbH $133,605 213 payments
  2. Boehringer Ingelheim Pharma GmbH & Co.KG $104,199 27 payments
Studies the money was for Research payments · program years 2019–2022
  1. Empagliflozin and heart failure (HFpEF) $158,913 150 payments
  2. Empagliflozin and Heart failure (HFrEF) $78,641 89 payments
  3. Empagliflozin and heart failure HFpEF $250 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record